CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Henry E. Blair, Chairman and Chief Executive Officer of Dyax, will present at the BIO CEO & Investor Conference, being held February 12-14 at The Waldorf-Astoria Hotel in New York, NY. Mr. Blair will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax Corp. presentation is scheduled for Monday, February 12th at 12:30 pm (ET).
